PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction

Li, Ming; Zhang, Weiwei; Zhang, Shenjun; Wang, Changhui; Lin, Yinping

doi:10.7150/jca.85747

Top

International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

open access Global reach, higher impact

PDF

J Cancer 2023; 14(8):1335. doi:10.7150/jca.85747 This issue Cite

Retraction

PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction

Ming Li^1,*, Weiwei Zhang^2,*, Shenjun Zhang³, Changhui Wang¹, Yinping Lin^1,3,

1. Department of Respiratory Medicine, Shanghai 10th People's Hospital, Tongji University, Shanghai 200072, China.
2. Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China
3. Institute of Biochemistry and Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
^*These authors have contributed equally to this work.

Citation:

Li M, Zhang W, Zhang S, Wang C, Lin Y. PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction. J Cancer 2023; 14(8):1335. doi:10.7150/jca.85747. https://www.jcancer.org/v14p1335.htm

Other styles

Retracted-article in J Cancer, Volume 8, 1795

After the article was published, the corresponding author found that the conclusions of the article were incomplete. To ensure scientific rigor, the corresponding author decided to retract the article. The first author, Dr. Li, agreed to retract the article, and the other authors did not reply whether they agreed to retract the article.

For the sake of scientific rigor, the corresponding author of the article, made a final decision to retract this paper.

Author contact

Corresponding author

Published 2023-5-15

Citation styles

APA

Li, M., Zhang, W., Zhang, S., Wang, C., Lin, Y. (2023). PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction. Journal of Cancer, 14(8), 1335. https://doi.org/10.7150/jca.85747.

ACS

Li, M.; Zhang, W.; Zhang, S.; Wang, C.; Lin, Y. PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction. J. Cancer 2023, 14 (8), 1335. DOI: 10.7150/jca.85747.

NLM

CSE

Li M, Zhang W, Zhang S, Wang C, Lin Y. 2023. PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction. J Cancer. 14(8):1335.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.